The Valley Desk

Clinical trial reportHematology (Amsterdam, Netherlands)Published

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Hematology (Amsterdam, Netherlands)
Published
Subject terms
Humans; Multiple Myeloma; Recurrence; Receptors, G-Protein-Coupled; Antibodies, Bispecific; Cohort Studies; Adult; Aged; Middle Aged; China; Female; Male
PubMed ID
42679119
Added to directory
Source checked

Report a correction or request removal